AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,426 | -88.9% | 18,585 | -82.2% | 0.00% | -90.9% |
Q2 2023 | $1,724,039 | +281.6% | 104,614 | +112.1% | 0.01% | +266.7% |
Q1 2023 | $451,817 | -59.9% | 49,325 | -68.6% | 0.00% | -57.1% |
Q4 2022 | $1,125,624 | +332.9% | 157,210 | +203.4% | 0.01% | +600.0% |
Q3 2022 | $260,000 | -22.2% | 51,809 | +25.2% | 0.00% | -66.7% |
Q4 2021 | $334,000 | +89.8% | 41,370 | +130.2% | 0.00% | +50.0% |
Q3 2021 | $176,000 | -49.3% | 17,973 | -73.9% | 0.00% | -60.0% |
Q3 2020 | $347,000 | +184.4% | 68,820 | +349.0% | 0.01% | +66.7% |
Q1 2020 | $122,000 | +84.8% | 15,326 | +41.6% | 0.00% | 0.0% |
Q2 2018 | $66,000 | -26.7% | 10,820 | -1.5% | 0.00% | -40.0% |
Q4 2017 | $90,000 | -51.1% | 10,982 | -37.4% | 0.01% | -50.0% |
Q3 2017 | $184,000 | – | 17,531 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |